GERON CORP
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
GERN$1.00+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31,2025 | December 31,2024 | |
|---|---|---|
| (In thousands, except share and per share data) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $77,560 | $79,016 |
| Restricted cash | 1,880 | 1,860 |
| Marketable securities | 280,359 | 327,550 |
| Accounts receivable, net | 36,987 | 35,946 |
| Interest and other receivables | 2,239 | 2,853 |
| Inventory | 116,636 | 38,714 |
| Prepaid and other current assets | 4,610 | 5,053 |
| Total current assets | 520,271 | 490,992 |
| Noncurrent marketable securities | 41,289 | 94,519 |
| Property and equipment, net | 884 | 1,310 |
| Operating leases, right-of-use assets | 2,151 | 2,881 |
| Deposits and other assets | 5,945 | 4,079 |
| $570,540 | $593,781 | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $11,257 | $8,595 |
| Accrued compensation and benefits | 30,497 | 22,808 |
| Operating lease liabilities | 1,000 | 974 |
| Liability related to sale of future royalties | 17,448 | 20,372 |
| Accrued liabilities | 51,340 | 35,549 |
| Total current liabilities | 111,542 | 88,298 |
| Noncurrent operating lease liabilities | 1,445 | 2,266 |
| Noncurrent liability related to sale of future royalties | 112,134 | 104,421 |
| Noncurrent debt | 119,547 | 118,476 |
| Total liabilities | 344,668 | 313,461 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and 2024 | — | — |
| Common stock, $0.001 par value; 1,350,000,000 shares authorized; 639,856,222 and 606,387,666 shares issued and outstanding at December 31, 2025 and 2024, respectively | 640 | 606 |
| Additional paid-in capital | 2,080,804 | 2,051,794 |
| Accumulated deficit | (1,855,841) | (1,772,341) |
| Accumulated other comprehensive income | 269 | 261 |
| Total stockholders' equity | 225,872 | 280,320 |
| $570,540 | $593,781 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.